Pharmacy costs of specialty medications for plaque psoriasis in the United States  Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Slides:



Advertisements
Similar presentations
Treatment of generalized lichen nitidus with narrowband ultraviolet B Jae-Hong Park, MD, Yun-Lim Choi, MD, Won-Serk Kim, MD, Dong-Youn Lee, MD, Jun-Mo.
Advertisements

Localized bullous fixed drug eruption following yellow fever vaccine
Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses  Michael Abrouk, BS, Benjamin Farahnik, BS, Tian Hao Zhu, BS, Mio Nakamura,
Tsung-Yu Tsai, MD, Yu-Chen Huang, MD 
Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis  Juan Escalas, PhD, MD, Nicole Knöpfel, MD, Ana Martin-Santiago,
Facial adenocarcinoma treated with intra-arterial chemotherapy
Volume 3, Issue 6, Pages (November 2017)
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Successful treatment of lipoatrophy with normal saline
Psoriasis: Latitude does make a difference
Baldness reversed by chemotherapy
Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 
CME examination Journal of the American Academy of Dermatology
Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 
Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.
Pediatric teledermatology: Observations based on 429 consults
Ana Corcimaru, BS, Dean S. Morrell, MD, Craig N. Burkhart, MD 
Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD 
Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting  Marisa.
Katherine E. Brick, BS, Robert H. Cook-Norris, MD, David A
The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis  Alan Menter, MD, Jennifer C. Cather, MD, Diane.
Assessing adherence with phototherapy protocols
Khanh P. Thieu, BS, Harley A. Haynes, MD 
Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial  William Tuong,
Smoking and risk of psoriasis: A nationwide cohort study
Pilot study of a skin cancer education curriculum for medical students
Kishore L. Jayakumar, BS, Sara S. Samimi, MD 
Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection  Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.
Seasonal variation of acne and psoriasis: A 3-year study using the Physician Global Assessment severity scale  Vanessa Lindsay Pascoe, MD, Alexandra Boer.
Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P
Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses  Michael Abrouk, BS, Benjamin Farahnik, BS, Tian Hao Zhu, BS, Mio Nakamura,
Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis  Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.
A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening  Dayoung Ko, BS, Shari R. Lipner, MD, PhD 
Partik Singh, BA, Jonathan I. Silverberg, MD, MPH, PhD 
Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks
Infectious rash after riding elephants
Robert Kantor, BS, Prarthana Dalal, BS, David Cella, PhD, Jonathan I
Lip edema Journal of the American Academy of Dermatology
Lip and oral mucosal lesions in 100 renal transplant recipients
Jeffrey Freed, MD, Jennifer Smith, MD 
Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions  Herbert C. Chiang, MD,
Pediatric psoriasis treated with apremilast
Hugh Gloster, MD, Chesahna Kindred, MBA 
Seasonal patterns in alopecia areata, totalis, and universalis
Appearance of lentigines in psoriasis patients treated with apremilast
Medicaid acceptance among pediatric dermatologists
Oral allergy syndrome and contact urticaria to apples
Penile calciphylaxis Journal of the American Academy of Dermatology
Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L
Tsung-Yu Tsai, MD, Yu-Chen Huang, MD 
Modification of the nail psoriasis severity index
Tofacitinib therapy for children with severe alopecia areata
Psoriasis localized exclusively to peristomal skin
Simple onycholysis: A diagnosis of exclusion
Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD 
Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C  Clara De Simone, MD, Andrea Paradisi, MD, Rodolfo Capizzi, MD, Angelo Carbone,
A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.
Toshiyuki Yamamoto, MD, Satoru Nakamura, MD, Kiyoshi Nishioka, MD 
An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis  James Krell, MD, FAAD, Candi Nelson, BS,
Eyebrow transplantation: Alternative body sites as a donor source
Gaps in pain management in dermatology: A needs assessment from Canada
Numerous hyperpigmented macules of the oral mucosa
Morphea in a patient undergoing treatment with ustekinumab
Brittany G. Craiglow, MD, Brett A. King, MD, PhD 
Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani  Erwin Suys, MD  Journal of the American Academy.
“Boot foot” with pseudomonas colonization
Stuart M. Goldsmith, MD, Armand B. Cognetta, MD 
Volume 5, Issue 7, Pages (July 2019)
Presentation transcript:

Pharmacy costs of specialty medications for plaque psoriasis in the United States  Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani, MD  Journal of the American Academy of Dermatology  Volume 80, Issue 1, Pages 274-275 (January 2019) DOI: 10.1016/j.jaad.2018.04.019 Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Trends in the costs of the first year of treatment per patient for specialty medications for plaque psoriasis from November 28, 2013, to October 4, 2017. Journal of the American Academy of Dermatology 2019 80, 274-275DOI: (10.1016/j.jaad.2018.04.019) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions